11 - Parenteral Delivery of Peptides and Proteins
References (0)
Cited by (4)
Matrikines as mediators of tissue remodelling
2022, Advanced Drug Delivery ReviewsCitation Excerpt :However, due to the invasive nature of these treatments, particularly the intravenous and intramuscular injections, they require outpatient therapy. Additionally, due to the short half-life of peptide drugs within the bloodstream, these often require frequent repeat injections, or a specially formulated slow-release system [254,255]. A recent study of peptide treatments currently in development has shown that current focus of delivery mechanism skews towards subcutaneous delivery due to the option of self-administration as well as reduced healthcare costs [252].
An expanding horizon of complex injectable products: development and regulatory considerations
2023, Drug Delivery and Translational ResearchStrategies for Formulation and Systemic Delivery of Therapeutic Proteins
2023, Protein-based TherapeuticsNanocarriers in Protein and Peptide Drug Delivery
2021, Nanocarriers: Drug Delivery System: An Evidence Based Approach
Copyright © 2011 Elsevier Inc. All rights reserved.